Reelsville, IN, United States of America

Roger Ryan Rothhaar

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger Ryan Rothhaar. Retrieved from https://idiyas.com/inventor/roger-ryan-rothhaar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 25.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 5(Granted Patents)

Company Filing History:

7 out of 4,514

Eli Lilly and Company

patents

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071423 - Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate (2024-08-27),

2. 11827618 - Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate (2023-11-28),

3. 8580780 - [object Object] (2013-11-12),

4. 8420631 - [object Object] (2013-04-16),

5. 8022062 - [object Object] (2011-09-20),

6. 7981882 - [object Object] (2011-07-19),

7. 7186715 - Piperazine- and piperidine-derivatives as melanocortin receptor agonists (2007-03-06),

8. 6881733 - Serotonergic benzofurans (2005-04-19),

Sure, I can help you with that. Let's start with the article about inventor Roger Ryan Rothhaar.

Title: Innovator Spotlight: Roger Ryan Rothhaar - Revolutionizing Pharmaceutical Processes in Reelsville, IN

Introduction:

In the heart of Reelsville, Indiana, an exceptional inventor is making waves in the pharmaceutical world. Roger Ryan Rothhaar, a distinguished innovator with seven patents under his belt, is reshaping the landscape of pharmaceutical preparations with his groundbreaking inventions.

Latest Patents:

Rothhaar's latest patents showcase his expertise in developing processes for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate. These inventions offer innovative formulations and product forms, such as tablets, with varying free base equivalents to cater to diverse medical needs.

Career Highlights:

Currently employed at Eli Lilly and Company, a renowned pharmaceutical giant, Rothhaar's contributions have significantly impacted the field of pharmaceuticals. His dedication to advancing drug development processes underscores his commitment to enhancing healthcare outcomes globally.

Collaborations:

Committed to fostering collaborative innovation, Rothhaar has worked closely with esteemed colleagues like Karin Briner and John Gordon Allen. Together, they have synergized their expertise to drive forward-thinking solutions in pharmaceutical research and development.

Conclusion:

In conclusion, Roger Ryan Rothhaar stands as a testament to the power of innovation and ingenuity in the pharmaceutical realm. His remarkable inventions and collaborative spirit exemplify the transformative impact that visionary inventors can have on shaping the future of healthcare. Reelsville, Indiana, and the pharmaceutical industry at large are undoubtedly enriched by Rothhaar's pioneering contributions.

Profile summary based on public USPTO records.